IDEAYA Biosciences, Inc.

NASDAQ:IDYA

Biotechnology

Healthcare
$26.17 -1.45%

-$0.45 today

Market cap
$2.53B
Beta
-0.05
P/E (TTM)
-19.5
EPS (TTM)
-$1.58
52W Low $20.50High $39.28

Volume 1.42M

Average 1.44M

Income Statement

Follow revenue through to earnings.

Revenue

$218.71M

FY 2025 · Annual

+3024.4% YoY

Operating Income

-$159.31M

FY 2025 · Annual

Net Income

-$113.70M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue27.94M50.93M23.39M7M218.71M
Cost of Revenue1.73M2.1M4.01M3.83M4.59M
Gross Profit26.22M48.83M19.38M3.17M214.12M
Gross Margin93.8%95.9%82.9%45.2%97.9%
Research & Development58.16M89.54M129.51M294.67M314.7M
Selling, General & Admin18.33M21.8M24.3M35.47M63.32M
Operating Expenses76.48M111.33M153.81M330.14M373.43M
Depreciation & Amortization1.73M2.1M4.01M3.83M4.59M
EBITDA(48.04M)(56.55M)(108.95M)(270.64M)(109.11M)
EBITDA Margin-171.9%-111.0%-465.9%-3866.3%-49.9%
Operating Income(50.27M)(62.5M)(134.43M)(326.98M)(159.31M)
Operating Margin-179.9%-122.7%-574.9%-4671.1%-72.8%
Interest Income506K3.85M21.47M52.5M45.62M
Interest Expense00000
Other Income / Expenses506K3.85M21.47M52.5M45.62M
Income Before Tax(49.76M)(58.66M)(112.96M)(274.48M)(113.7M)
Pre-Tax Margin-178.1%-115.2%-483.0%-3921.1%-52.0%
Income Tax Expense00000
Net Income(49.76M)(58.66M)(112.96M)(274.48M)(113.7M)
Net Margin-178.1%-115.2%-483.0%-3921.1%-52.0%
EPS (Basic)(1.41)(1.42)(1.96)(3.36)(1.28)
EPS (Diluted)(1.41)(1.42)(1.96)(3.36)(1.28)
Weighted Avg Shares35.25M41.44M57.52M81.68M88.49M
Weighted Avg Shares (Diluted)35.25M41.44M57.52M81.68M88.49M

IDYA Earnings Waterfall · TTM

NASDAQ:IDYA · Revenue to Net Income

Key Ratios

EPS$-1.60
Gross Margin-138.4%
Net Margin-552.6%
P/E Ratio-4.4
P/S Ratio186.0

Analysis

$225.3M of revenue converted into -$140.1M of net income for the selected period. Gross margin is -138.4% and net margin is -552.6%, showing how much revenue survives after costs and taxes. EPS is $-1.60, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
S-8S-8 filingNov 3, 2026
8-KCurrent reportNov 3, 2026
10-QQuarterly reportNov 3, 2026
4Statement of changes in beneficial ownershipOct 8, 2026
SC 13GSC 13G filingAug 14, 2026

How much revenue does IDYA generate?

IDEAYA Biosciences, Inc. (IDYA) reported $218.71M of revenue in fiscal 2025.

Is IDYA profitable?

IDEAYA Biosciences, Inc. (IDYA) reported -$113.70M of net income, with a net margin of -52.0%.